美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

美國抗疫概念

1,467.14

-3.0465-0.21%

漲家數：10

跌家數：10

平家數：- -

市盈率：- -

高：1,469.90

開：1,469.76

低：1,454.86

收：1,470.19

資料載入中...

總覽新聞資訊

Corvus Pharmaceuticals, Inc.盤中異動臨近收盤股價大跌5.06%

美國OTC市場Ampio Pharmaceuticals Inc盤中異動急速拉昇1352.38%

Equillium, Inc.盤中異動股價大漲5.87%報0.810美元

Co-Diagnostics, Inc.盤中異動早盤快速上漲5.13%報0.546美元

美股異動｜諾瓦瓦克斯醫藥漲超9% Q4淨虧損同比收窄正加快研發新疫苗

港股那点事

美股異動 | 報道稱美國政府考慮撤回對公司禽流感疫苗的資助 Moderna(MRNA.US)跌超6%

Moderna(MRNA.O)跌7.1%，因有報道顯示美國總統特朗普政府考慮撤回對該公司禽流感疫苗的資助。

伊諾維奧製藥盤中異動早盤急速上漲5.05%

諾瓦瓦克斯醫藥漲超4.5% Q4虧損有所收窄

美股異動 | 諾瓦瓦克斯醫藥(NVAX.US)漲超4.5% Q4虧損有所收窄

Ocugen, Inc.盤中異動股價大漲5.20%報0.642美元

莫德納盤中異動早盤股價大跌5.14%報31.86美元

諾瓦瓦克斯醫藥盤中異動早盤急速上漲5.60%報7.73美元

Vir Biotechnology, Inc.盤中異動急速拉昇5.98%報9.75美元

Movement首個Meme幣GMOVE針對Movement測試網用户開啓大規模空投，查詢網站已上線

Movement首個Meme幣GMOVE針對Movement測試網用户開啓大規模空投，查詢網站已上線

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4568/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美國抗疫概念","latestPrice":1467.1393,"timestamp":1741294799999,"preClose":1470.1858,"halted":0,"volume":105316851,"delay":0,"changeRate":-0.002072,"change":-3.046509,"pbRate":4.026038,"amount":5672830084.087859,"amplitude":0.01023,"prevYearClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"turnoverRate":0.00681,"marketCap":1210199793589.5,"floatMarketCap":1188113526137,"peRate":31.895692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1469.9016,"amplitude":0.01023,"preClose":1470.1858,"low":1454.8619,"pbRate":"4.026038","latestPrice":1467.1393,"volume":105316852,"delay":0,"open":1469.7611,"prevYearClose":1274.8187,"prevWeekClose":1463.5875,"prevMonthClose":1463.5875,"prevQuarterClose":1274.8187,"fiveDayClose":1446.7607,"twentyDayClose":1373.9138,"sixtyDayClose":1299.5834,"secType":"PLATE","market":"US","turnoverRate":0.00681,"peRate":31.895692,"marketCap":1210199793589.5,"floatMarketCap":1188113526137,"timestamp":1741294799999,"nameCN":"美國抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":10,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:16,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514433086","title":"Corvus Pharmaceuticals, Inc.盤中異動 臨近收盤股價大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514433086","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514433086?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 04:57","pubTimestamp":1740689829,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时57分，Corvus Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.06%。Corvus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1955.27%、424.52%、198.31%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Corvus Pharmaceuticals, Inc.公司简介：Corvus Pharmaceuticals Inc 是一家临床阶段的生物制药公司，致力于开发针对免疫系统关键细胞元素的药物和抗体。其他产品包括Ciforadenant 和Mupadolimab 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228045710a256d079&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","CRVS"],"gpt_icon":0},{"id":"2514331790","title":"美國OTC市場Ampio Pharmaceuticals Inc盤中異動 急速拉昇1352.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514331790?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 03:24","pubTimestamp":1740684241,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日03时24分，美国OTC市场Ampio Pharmaceuticals Inc股票出现波动，股价大幅上涨1352.38%。美国OTC市场Ampio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.06%。美国OTC市场Ampio Pharmaceuticals Inc公司简介：Ampio Pharmaceuticals Inc是一家生物制药公司。其候选产品Ampion正在进行临床试验，并被开发用于治疗严重的膝关节骨性关节炎，对COVID-19患者进行静脉治疗，以及对COVID-19引起的呼吸窘迫进行吸入治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032401abdfaf19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228032401abdfaf19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AMPE","BK4535","BK4588","BNTX","BK4007","BK4551","BK4585","BK4548","BK4139","BK4568"],"gpt_icon":0},{"id":"2514132339","title":"Equillium, Inc.盤中異動 股價大漲5.87%報0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514132339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514132339?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 02:59","pubTimestamp":1740682746,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日02时59分，Equillium, Inc.股票出现波动，股价大幅上涨5.87%。截至发稿，该股报0.810美元/股，成交量2.9874万股，换手率0.08%，振幅6.54%。Equillium, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1880.38%、320.93%、136.91%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Pepgen Inc.，振幅分别为86.14%、55.84%、52.94%。Equillium, Inc.公司简介：Equillium Inc 是一家开发治疗自身免疫和炎症疾病的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280259069632e33a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","EQ"],"gpt_icon":0},{"id":"2514338736","title":"Co-Diagnostics, Inc.盤中異動 早盤快速上漲5.13%報0.546美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514338736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514338736?lang=zh_tw&edition=fundamental","pubTime":"2025-02-28 00:25","pubTimestamp":1740673537,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时25分，Co-Diagnostics, Inc.股票出现波动，股价大幅拉升5.13%。截至发稿，该股报0.546美元/股，成交量6.9108万股，换手率0.22%，振幅8.73%。Co-Diagnostics, Inc.股票所在的医疗器械行业中，整体涨幅为0.01%。Co-Diagnostics, Inc.公司简介：Co-Diagnostics Inc是一家分子诊断公司。该公司还利用其专有技术为其 Co-Dx PCR 平台设计特定测试，并定位用于传染病以外应用的遗传标记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800253798952734&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800253798952734&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4082","CODX"],"gpt_icon":0},{"id":"2514538166","title":"美股異動｜諾瓦瓦克斯醫藥漲超9% Q4淨虧損同比收窄 正加快研發新疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2514538166","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514538166?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:26","pubTimestamp":1740669960,"startTime":"0","endTime":"0","summary":"格隆汇2月27日｜诺瓦瓦克斯医药(NVAX.US)涨超9%，报8美元。消息面上，诺瓦瓦克斯医药第四季度财报显示，净亏损为8100万美元，而去年同期净亏损为1.783亿美元，亏损收窄主要受益于新冠疫苗销售和管理费用的减少。期内新冠疫苗销售额仅为4980万美元，同比下降80.2%。面对市场需求疲软，公司正寄望于与Sanofi的合作带来的收入增长，同时加快推进新疫苗的研发。(格隆汇)               \n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-02-27/doc-inemxzxx7586100.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4547","BK4588","BK4139","NVAX","159646","BK4568","BK4585"],"gpt_icon":0},{"id":"2514081389","title":"美股異動 | 報道稱美國政府考慮撤回對公司禽流感疫苗的資助 Moderna(MRNA.US)跌超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514081389","media":"智通财经","labels":["policyRegulatory","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514081389?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 23:19","pubTimestamp":1740669544,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，Moderna(MRNA.US)跌超6%，报31.66美元。消息面上，报道称，知情人士表示特朗普政府正在权衡撤销对Moderna禽流感疫苗的资助，该合同价值约5.9亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255818.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","MRNA","BK4139","BK4501","BK4534","BK4551","BK4568","BK4548","BK4588","BK4532","BK4585","BK4533"],"gpt_icon":0},{"id":"2514385244","title":"Moderna(MRNA.O)跌7.1%，因有報道顯示美國總統特朗普政府考慮撤回對該公司禽流感疫苗的資助。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385244","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385244?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:51","pubTimestamp":1740667905,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4588","BK4585","BK4532","BK4501","BK4534","MRNA","BK4533","BK4568","BK4548","BK4139","159646","BK4551"],"gpt_icon":0},{"id":"2514857133","title":"伊諾維奧製藥盤中異動 早盤急速上漲5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514857133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514857133?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:47","pubTimestamp":1740667654,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时47分，伊诺维奥制药股票出现波动，股价急速拉升5.05%。截至发稿，该股报2.08美元/股，成交量5.7309万股，换手率0.16%，振幅4.80%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.80%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224734a2567e46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224734a2567e46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INO","BK4139","BK4583","BK4568"],"gpt_icon":0},{"id":"2514389327","title":"諾瓦瓦克斯醫藥漲超4.5% Q4虧損有所收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2514389327","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514389327?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:47","pubTimestamp":1740667630,"startTime":"0","endTime":"0","summary":"周四，诺瓦瓦克斯医药(NVAX.US)股价走高，截至发稿，该股涨超4.5%，报7.61美元。在最新公布的第四季度财报显示，公司亏损有所收窄，主要受益于新冠疫苗销售和管理费用的减少。目前，该疫苗仍是诺瓦瓦克斯医药唯一在售的产品。截至12月31日的季度，其净亏损为8100万美元，而去年同期净亏损为1.783亿美元。诺瓦瓦克斯医药第四季度新冠疫苗销售额仅为4980万美元，同比大幅下降80.2%。面对市场需求疲软，公司正寄望于与Sanofi的合作带来的收入增长，同时加快推进新疫苗的研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225506a2567fe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227225506a2567fe3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVAX","BK4585","BK4568","BK4547","BK4588"],"gpt_icon":0},{"id":"2514859573","title":"美股異動 | 諾瓦瓦克斯醫藥(NVAX.US)漲超4.5% Q4虧損有所收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859573","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514859573?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:36","pubTimestamp":1740666987,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，诺瓦瓦克斯医药(NVAX.US)股价走高，截至发稿，该股涨超4.5%，报7.61美元。在最新公布的第四季度财报显示，公司亏损有所收窄，主要受益于新冠疫苗销售和管理费用的减少。目前，该疫苗仍是诺瓦瓦克斯医药唯一在售的产品。截至12月31日的季度，其净亏损为8100万美元，而去年同期净亏损为1.783亿美元。诺瓦瓦克斯医药第四季度新冠疫苗销售额仅为4980万美元，同比大幅下降80.2%。面对市场需求疲软，公司正寄望于与Sanofi的合作带来的收入增长，同时加快推进新疫苗的研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255764.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","BK4568","NVAX","BK4139","BK4547"],"gpt_icon":0},{"id":"2514138579","title":"Ocugen, Inc.盤中異動 股價大漲5.20%報0.642美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514138579?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:36","pubTimestamp":1740666971,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时36分，Ocugen, Inc.股票出现波动，股价大幅上涨5.20%。截至发稿，该股报0.642美元/股，成交量74.168万股，换手率0.25%，振幅4.49%。Ocugen, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Ocugen, Inc.公司简介：Ocugen Inc公司专注于发现、开发和商业化新型基因和细胞疗法以及疫苗，旨在改善健康并为全球患者带来希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223611a2567b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223611a2567b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","OCGN","BK4563","BK4139"],"gpt_icon":0},{"id":"2514385798","title":"莫德納盤中異動 早盤股價大跌5.14%報31.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385798?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:34","pubTimestamp":1740666865,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时34分，莫德纳股票出现波动，股价急速下挫5.14%。截至发稿，该股报31.86美元/股，成交量92.5956万股，换手率0.24%，振幅3.37%。莫德纳股票所在的生物技术行业中，整体涨幅为0.42%。莫德纳公司简介：莫德纳是一家商业阶段的生物技术公司，成立于 2010 年，并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证，该疫苗于 2020 年 12 月在美国获得批准。截至 2024年9月，莫德纳拥有处于临床试验中的40个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272234259632b15e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272234259632b15e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4501","BK4588","BK4551","BK4532","BK4585","MRNA","BK4568","BK4139","BK4534","BK4533","BK4548"],"gpt_icon":1},{"id":"2514538363","title":"諾瓦瓦克斯醫藥盤中異動 早盤急速上漲5.60%報7.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514538363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514538363?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:31","pubTimestamp":1740666668,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，诺瓦瓦克斯医药股票出现异动，股价快速拉升5.60%。截至发稿，该股报7.73美元/股，成交量29.2256万股，换手率0.18%，振幅2.46%。诺瓦瓦克斯医药股票所在的生物技术行业中，整体涨幅为0.06%。诺瓦瓦克斯医药公司简介：诺瓦瓦克斯医药公司是一家开发疫苗的生物技术公司。诺瓦瓦克斯与其全资拥有的瑞典子公司合作生产候选疫苗，以应对已知和新出现的疾病威胁。该公司认为，其疫苗技术有可能广泛应用于各种人类传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223108abdf6e56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223108abdf6e56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVAX","BK4585","BK4568","BK4547","BK4588"],"gpt_icon":0},{"id":"2514385741","title":"Vir Biotechnology, Inc.盤中異動 急速拉昇5.98%報9.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514385741?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:31","pubTimestamp":1740666662,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Vir Biotechnology, Inc.股票出现波动，股价急速上涨5.98%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310298950fe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310298950fe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","VIR","BK4568","BK4585"],"gpt_icon":0},{"id":"2514655381","title":"Movement首個Meme幣GMOVE針對Movement測試網用户開啓大規模空投，查詢網站已上線","url":"https://stock-news.laohu8.com/highlight/detail?id=2514655381","media":"世链财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514655381?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:18","pubTimestamp":1740665880,"startTime":"0","endTime":"0","summary":"2 月 27 日，据官方消息，Movement 链 Meme 币 GMOVE 启动大规模空投，完成对 Movement 测试网、以太坊活跃用户以及 SUI 和 APT 上 18 个知名 Memecoin 和 NFT 持有者快照，并上线空投查询功能。用户可以在 GMOVE 官网输入 MOVE 或 EV","market":"hk","thumbnail":"https://m.shilian.com/assets/addons/cms/img/noimage/15.jpg","type":0,"news_type":0,"thumbnails":["https://m.shilian.com/assets/addons/cms/img/noimage/15.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.shilian.com//kuaixun/786294.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"shilian_live","symbols":["03009","ETHW","SUI","09046","BK4173","IBIT","BK4585","HIPO","QETH","09179","ETHA","BK4170","BK4594","EVM","03179","03046","BK1611","DEEP","APT","BK4601","ETH.USD.CC","MOVE","FETH","CETH","BK4215","ETH","BK4228","APT.USD.CC","EZET","BK4086","09009","LDO.USD.HKCC","ETH.USD.HKCC","BK4568","ETHV","APT.USD.HKCC","OP.USD.HKCC","BK4588","ETHE"],"gpt_icon":0},{"id":"2514850503","title":"Movement首個Meme幣GMOVE針對Movement測試網用户開啓大規模空投，查詢網站已上線","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850503","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514850503?lang=zh_tw&edition=fundamental","pubTime":"2025-02-27 22:16","pubTimestamp":1740665760,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/283479","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["ETHE","BK4568","IBIT","03046","BK4585","BK4215","ETH","BK4086","MOVE","BK4594","09179","CETH","BK4173","DEEP","BK4601","ETHA","09009","09046","03009","APT.USD.HKCC","EVM","EZET","BK1611","BK4170","APT","ETH.USD.CC","SUI","ETHV","BK4588","LDO.USD.HKCC","03179","BK4228","OP.USD.HKCC","APT.USD.CC","HIPO","ETHW","QETH","FETH","ETH.USD.HKCC"],"gpt_icon":0}],"pageSize":16,"totalPage":11,"pageCount":5,"totalSize":161}]}}